文献速递临床试验与 GCP基础与转化研究

术中目标导向液体治疗与限制性液体治疗联合加速康复外科方案对高危患者胸腔镜肺叶切除术后并发症的影响:前瞻性随机对照试验研究方案

Effects of intraoperative goal-directed fluid therapy and restrictive fluid therapy combined with enhanced recovery after surgery protocol on complications after thoracoscopic lobectomy in high-risk patients: study protocol for a prospective randomized controlled trial.
PubMed 文献 · Trials · 2021-01-07

主要结局为术后急性肾损伤(AKI)发生率,次要结局包括肾脏替代治疗、ICU停留时间、住院时间及其他并发症。假设限制性液体治疗在降低AKI发生率方面非劣于GDFT,且更简便易行。

要点

  • 高危患者胸腔镜肺叶切除术后AKI常见,与术中输液不足相关。
  • ERAS方案推荐限制性液体治疗,GDFT可个体化调整输液。
  • 本研究首次对比GDFT与限制性液体治疗联合ERAS对术后AKI的影响。

核心结论

  • 假设限制性液体治疗在降低高危患者胸腔镜肺叶切除术后AKI发生率方面非劣于GDFT,且更简便易行。

关键数值与推荐

  • 主要结局为术后AKI发生率。
  • 次要结局包括肾脏替代治疗发生率、术后ICU停留时间、术后住院时间及感染、急性肺损伤、肺炎、心律失常、心力衰竭、非心脏手术后心肌损伤和心肌梗死等其他并发症发生率。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Acute kidney injury (AKI) is a common complication after thoracoscopic lobectomy in high-risk patients due to insufficient intraoperative infusion. Goal-directed fluid therapy (GDFT) is an individualized fluid infusion strategy; the fluid infusion strategy is adjusted according to the patient's fluid response. GDFT during operation can reduce the incidence of AKI after major surgery. Enhanced recovery after surgery (ERAS) protocol optimizes perioperative interventions to decrease the postoperative complications after surgery. In ERAS protocol of lobectomy, intraoperative restrictive fluid therapy is recommended. In this study, we will compare the effects of intraoperative GDFT with restrictive fluid therapy combined with an ERAS protocol on the incidence of AKI after thoracoscopic lobectomy in high-risk patients. METHODS/DESIGN: This is a prospective single-center single-blind randomized controlled trial. Two hundred seventy-six patients scheduled for thoracoscopic lobectomy are randomly allocated to receive either GDFT or restrictive fluid therapy combined with an ERAS protocol at a 1:1 ratio. The primary outcome is the incidence of AKI after operation. The secondary outcomes include (1) the incidence of renal replacement therapy, (2) the length of intensive care unit stay after operation, (3) the length of hospital stay after operation, and (4) the incidence of other complications including infection, acute lung injury, pneumonia, arrhythmia, heart failure, myocardial injury after noncardiac surgery, and cardiac infarction. DISCUSSION: This is the first study to compare intraoperative GDFT with restrictive fluid therapy combined with an ERAS protocol on the incidence of AKI after thoracoscopic lobectomy in high-risk patients. The hypothesis is that the restrictive fluid therapy is noninferior to GDFT in reducing the incidence of AKI, but restrictive fluid therapy is simpler to apply than GDFT. TRIAL REGISTRATION: ClinicalTrials.gov NCT04302467 . Registered on 26 February 2020.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Guan Z, Gao Y, Qiao Q, et al. Effects of intraoperative goal-directed fluid therapy and restrictive fluid therapy combined with enhanced recovery after surgery protocol on complications after thoracoscopic lobectomy in high-risk patients: study protocol for a prospective randomized controlled trial. Trials. 2021. PMID: 33413593. doi:10.1186/s13063-020-04983-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。